• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Celgene Corporation (CELG)

    -NasdaqGS
    103.16 Up 2.66(2.65%) Feb 10, 4:00PM EST
    |After Hours : 102.68 Down 0.48 (0.47%) Feb 10, 7:59PM EST
    Prev Close:100.50
    Open:101.84
    Bid:97.40 x 400
    Ask:103.84 x 100
    1y Target Est:139.29
    Beta:1.86499
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:101.17 - 105.98
    52wk Range:92.98 - 140.72
    Volume:8,024,404
    Avg Vol (3m):6,023,530
    Market Cap:81.05B
    P/E (ttm):53.18
    EPS (ttm):1.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 2.65%81.05B
    JNJDown 0.24%281.48B

    Key Statistics

    Forward P/E (1 yr):14.29
    P/S (ttm):8.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.72
    Quarterly EPS Est (Mar-16) :1.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback